GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Net Margin %

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Net Margin % : -223.36% (As of Nov. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Cannabis Bioscience International Holdings's Net Income for the six months ended in Nov. 2023 was $-0.31 Mil. Cannabis Bioscience International Holdings's Revenue for the six months ended in Nov. 2023 was $0.14 Mil. Therefore, Cannabis Bioscience International Holdings's net margin for the quarter that ended in Nov. 2023 was -223.36%.

The historical rank and industry rank for Cannabis Bioscience International Holdings's Net Margin % or its related term are showing as below:

CBIH' s Net Margin % Range Over the Past 10 Years
Min: -223.36   Med: -2.81   Max: 15.67
Current: -223.36


CBIH's Net Margin % is ranked worse than
89.4% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.28 vs CBIH: -223.36

Cannabis Bioscience International Holdings Net Margin % Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Net Margin % Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11
Net Margin %
-116.67 - 15.67 -18.15 12.53

Cannabis Bioscience International Holdings Semi-Annual Data
Dec06 Jun07 Dec07 Jun08 May09 Nov09 May10 Nov10 May11 Nov11 Nov22 Nov23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.79 4.41 14.95 -197.26 -223.36

Competitive Comparison of Cannabis Bioscience International Holdings's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Net Margin % falls into.



Cannabis Bioscience International Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Cannabis Bioscience International Holdings's Net Margin for the fiscal year that ended in May. 2011 is calculated as

Net Margin=Net Income (A: May. 2011 )/Revenue (A: May. 2011 )
=10.457/83.461
=12.53 %

Cannabis Bioscience International Holdings's Net Margin for the quarter that ended in Nov. 2023 is calculated as

Net Margin=Net Income (Q: Nov. 2023 )/Revenue (Q: Nov. 2023 )
=-0.306/0.137
=-223.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Cannabis Bioscience International Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Headlines